With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Investigating Epigenetic Mechanisms of Response to Allogenic CAR T Cell Therapy||St. Jude Children's Research Hospital / Caitlin Zebley, MD/PhD||Young Investigator Grants||2021||Tennessee|
|Neural Crest Gene Regulatory Networks Underlying Normal Meningeal Development and Onset of Meningioma||California Institute of Technology / Ayyappa Raja Desingu Rajan, PhD||Young Investigator Grants||2021||California|
|Function and Dependency of NFkB Activity in ZFTA-RELA Fusion Ependymoma||Baylor College of Medicine / Austin Stuckert, MD||Young Investigator Grants||2021||Texas|
|Characterizing Inflammatory Phenotypes Associated with RUNX1 Deficiency||Dana-Farber Cancer Institute / Waihay Wong, MD/PhD||RUNX1 Early Career Investigator Grants||2021||Massachusetts|
|Role of PHF6 Mutations in Germline RUNX1 Deficiency Associated Hematopoietic Disorders||The Regents of the University of California San Francisco / Serine Avagyan, MD/PhD||RUNX1 Early Career Investigator Grants||2021||California|
|Turning Killers into THINKers: TME Hostility-Impervious NK Cells for Treating Neuroblastoma and Sarcoma||Baylor College of Medicine / Robin Parihar, MD/PhD||'A' Award Grants||2021||Texas|
|Circulating Tumor Biomarkers: New Paradigms for Management of Neuroblastoma||University of Chicago / Mark Applebaum, PhD||'A' Award Grants||2021||Illinois|
|The Interplay Between Histone Mutations and Replication Stress in Shaping Glioma Phenotypes||Dana-Farber Cancer Institute / Pratiti Bandopadhayay, PhD||'A' Award Grants||2021||Massachusetts|
|IND-Enabling Studies for WNTinib, a Novel Selective Therapeutic for CTNNB1 Mutant Hepatoblastomas||Icahn School of Medicine at Mount Sinai / Ernesto Guccione, PhD & Josep Llovet, MD & Arvin Dar, PhD||Reach Grants||2021||New York|
|Optimization of Drug Efflux and Brain Clearance to Improve CED of Targeted Therapy to H3K27M DMG||Mayo Clinic / David Daniels, MD/PhD||Reach Grants||2021||Minnesota|